Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 08, 2016 4:00 AM ET

Pharmaceuticals

Company Overview of Actavis UK Ltd

Company Overview

Actavis UK Ltd develops, manufactures, and distributes generic, branded, and biosimilar pharmaceutical products. It offers alenvona and cleosensa tablets, neotigason tablets, paracetamol solutions (for infusion), over-the-counter products, and fentanyl transdermal patch solutions. The company provides its products for the treatment of diseases in central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory, and anti-infective therapeutic categories. It serves patients and healthcare professionals worldwide. The company was founded in 1903 and is based in Barnstaple, United Kingdom with manufacturing and distribution facilities in the United Kingdom and inter...

Whiddon Valley

Barnstaple,  EX32 8NS

United Kingdom

Founded in 1903

Phone:

44 12 7131 1200

Fax:

44 12 7134 6106

Key Executives for Actavis UK Ltd

Executive Director of Finance & Information Technology
Managing Director of Operations
Executive Director of Human Resources
Vice President of UK & Ireland
Executive Director of Hospitals & Brands and Director
Compensation as of Fiscal Year 2015.

Actavis UK Ltd Key Developments

Actavis UK Wins GBP 12.4 Million Multiple Awardees Contract for Supplying Analgesic, Anaesthetic, Musculoskeletal and Joint Disease Medicines

Actavis UK Ltd., Barnstaple, won a GBP 12.4 million (excluding VAT) multiple awardees contract award from The Common Services Agency (more commonly known as NHS National Services Scotland) for the supply of a range of analgesic, anaesthetic, musculoskeletal and joint disease medicines (Oxycodone Modified and Prolonged Release Tablets). This Framework Agreement is for the supply of a range of Analgesic, Anaesthetic, Musculoskeletal and Joint Disease Medicines to NHS Scotland.

Actavis UK Ltd. Wins GBP 162.3 Million Multiple Awardees Contract

Actavis UK Ltd. won a GBP 162.3 million (excluding VAT) multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for branded pharmaceuticals (Contract Award Notice No.: 2015/S 237-430145).

Actavis UK Ltd. Wins GBP 11.2 Million Multiple Awardees Contract for Supplying Psychiatry Medicines

Actavis UK Ltd. won a GBP 11.2 million multiple awardees contract award from The Common Services Agency (more commonly known as NHS National Services Scotland) for the supply of psychiatry medicines (Lamotrigine presentations) (Contract Award Notice No.: 2015/S 162-296520; Lot No.: 2).

Similar Private Companies By Industry

Company Name Region
Funxional Therapeutics Ltd. Europe
Dashtag Limited Europe
Archimedes Pharma Limited Europe
Evotec (UK) Ltd. Europe
Lofthouse of Fleetwood Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Actavis UK Ltd, please visit www.actavis.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.